Logo image of ABO.BR

ABO GROUP ENVIRONMENT (ABO.BR) Stock Fundamental Analysis

EBR:ABO - Euronext Brussels - BE0974278104 - Common Stock - Currency: EUR

4.3  0 (0%)

Fundamental Rating

6

Taking everything into account, ABO scores 6 out of 10 in our fundamental rating. ABO was compared to 44 industry peers in the Commercial Services & Supplies industry. While ABO has a great profitability rating, there are some minor concerns on its financial health. ABO is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, ABO could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ABO had positive earnings in the past year.
ABO had a positive operating cash flow in the past year.
ABO had positive earnings in each of the past 5 years.
Each year in the past 5 years ABO had a positive operating cash flow.
ABO.BR Yearly Net Income VS EBIT VS OCF VS FCFABO.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

1.2 Ratios

ABO has a better Return On Assets (2.78%) than 69.57% of its industry peers.
ABO's Return On Equity of 9.16% is fine compared to the rest of the industry. ABO outperforms 63.04% of its industry peers.
ABO's Return On Invested Capital of 7.84% is fine compared to the rest of the industry. ABO outperforms 76.09% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ABO is in line with the industry average of 7.74%.
The last Return On Invested Capital (7.84%) for ABO is above the 3 year average (6.79%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.78%
ROE 9.16%
ROIC 7.84%
ROA(3y)3.03%
ROA(5y)3.28%
ROE(3y)10.2%
ROE(5y)10.82%
ROIC(3y)6.79%
ROIC(5y)7.33%
ABO.BR Yearly ROA, ROE, ROICABO.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 2.60%, ABO perfoms like the industry average, outperforming 58.70% of the companies in the same industry.
In the last couple of years the Profit Margin of ABO has grown nicely.
ABO's Operating Margin of 5.33% is in line compared to the rest of the industry. ABO outperforms 58.70% of its industry peers.
ABO's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 87.31%, ABO belongs to the best of the industry, outperforming 91.30% of the companies in the same industry.
In the last couple of years the Gross Margin of ABO has remained more or less at the same level.
Industry RankSector Rank
OM 5.33%
PM (TTM) 2.6%
GM 87.31%
OM growth 3Y-6.44%
OM growth 5Y11.16%
PM growth 3Y-11.25%
PM growth 5Y19.73%
GM growth 3Y-0.84%
GM growth 5Y-0.31%
ABO.BR Yearly Profit, Operating, Gross MarginsABO.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 20 40 60 80

5

2. Health

2.1 Basic Checks

ABO has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ABO remains at a similar level compared to 1 year ago.
The number of shares outstanding for ABO remains at a similar level compared to 5 years ago.
Compared to 1 year ago, ABO has an improved debt to assets ratio.
ABO.BR Yearly Shares OutstandingABO.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
ABO.BR Yearly Total Debt VS Total AssetsABO.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

An Altman-Z score of 2.18 indicates that ABO is not a great score, but indicates only limited risk for bankruptcy at the moment.
ABO's Altman-Z score of 2.18 is fine compared to the rest of the industry. ABO outperforms 73.91% of its industry peers.
The Debt to FCF ratio of ABO is 7.35, which is on the high side as it means it would take ABO, 7.35 years of fcf income to pay off all of its debts.
ABO has a Debt to FCF ratio (7.35) which is comparable to the rest of the industry.
ABO has a Debt/Equity ratio of 0.57. This is a neutral value indicating ABO is somewhat dependend on debt financing.
ABO's Debt to Equity ratio of 0.57 is fine compared to the rest of the industry. ABO outperforms 63.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 7.35
Altman-Z 2.18
ROIC/WACC1.39
WACC5.65%
ABO.BR Yearly LT Debt VS Equity VS FCFABO.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

2.3 Liquidity

ABO has a Current Ratio of 1.16. This is a normal value and indicates that ABO is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.16, ABO is in line with its industry, outperforming 47.83% of the companies in the same industry.
A Quick Ratio of 1.13 indicates that ABO should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.13, ABO is doing good in the industry, outperforming 67.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.16
Quick Ratio 1.13
ABO.BR Yearly Current Assets VS Current LiabilitesABO.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 41.21% over the past year.
Measured over the past years, ABO shows a very strong growth in Earnings Per Share. The EPS has been growing by 35.88% on average per year.
ABO shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.68%.
Measured over the past years, ABO shows a quite strong growth in Revenue. The Revenue has been growing by 13.50% on average per year.
EPS 1Y (TTM)41.21%
EPS 3Y5.8%
EPS 5Y35.88%
EPS Q2Q%-31.17%
Revenue 1Y (TTM)21.68%
Revenue growth 3Y19.22%
Revenue growth 5Y13.5%
Sales Q2Q%14.27%

3.2 Future

ABO is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.28% yearly.
Based on estimates for the next years, ABO will show a quite strong growth in Revenue. The Revenue will grow by 18.30% on average per year.
EPS Next Y30.1%
EPS Next 2YN/A
EPS Next 3Y13.28%
EPS Next 5YN/A
Revenue Next Year8.5%
Revenue Next 2YN/A
Revenue Next 3Y18.3%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ABO.BR Yearly Revenue VS EstimatesABO.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 20M 40M 60M 80M 100M
ABO.BR Yearly EPS VS EstimatesABO.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 0.1 0.2 0.3 0.4 0.5

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 19.55, ABO is valued on the expensive side.
Based on the Price/Earnings ratio, ABO is valued a bit cheaper than 63.04% of the companies in the same industry.
When comparing the Price/Earnings ratio of ABO to the average of the S&P500 Index (29.35), we can say ABO is valued slightly cheaper.
ABO is valuated reasonably with a Price/Forward Earnings ratio of 8.74.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ABO indicates a rather cheap valuation: ABO is cheaper than 84.78% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of ABO to the average of the S&P500 Index (22.10), we can say ABO is valued rather cheaply.
Industry RankSector Rank
PE 19.55
Fwd PE 8.74
ABO.BR Price Earnings VS Forward Price EarningsABO.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ABO's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. ABO is cheaper than 78.26% of the companies in the same industry.
ABO's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 11.14
EV/EBITDA 5.69
ABO.BR Per share dataABO.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of ABO may justify a higher PE ratio.
ABO's earnings are expected to grow with 13.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.65
PEG (5Y)0.54
EPS Next 2YN/A
EPS Next 3Y13.28%

0

5. Dividend

5.1 Amount

No dividends for ABO!.
Industry RankSector Rank
Dividend Yield N/A

ABO GROUP ENVIRONMENT

EBR:ABO (3/7/2025, 7:00:00 PM)

4.3

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.28%
Inst Owner ChangeN/A
Ins Owners85.52%
Ins Owner ChangeN/A
Market Cap45.45M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 19.55
Fwd PE 8.74
P/S 0.51
P/FCF 11.14
P/OCF 5.15
P/B 1.8
P/tB 2.55
EV/EBITDA 5.69
EPS(TTM)0.22
EY5.12%
EPS(NY)0.49
Fwd EY11.44%
FCF(TTM)0.39
FCFY8.97%
OCF(TTM)0.84
OCFY19.42%
SpS8.45
BVpS2.39
TBVpS1.68
PEG (NY)0.65
PEG (5Y)0.54
Profitability
Industry RankSector Rank
ROA 2.78%
ROE 9.16%
ROCE 10.38%
ROIC 7.84%
ROICexc 9.51%
ROICexgc 11.86%
OM 5.33%
PM (TTM) 2.6%
GM 87.31%
FCFM 4.57%
ROA(3y)3.03%
ROA(5y)3.28%
ROE(3y)10.2%
ROE(5y)10.82%
ROIC(3y)6.79%
ROIC(5y)7.33%
ROICexc(3y)11.7%
ROICexc(5y)12.37%
ROICexgc(3y)14.41%
ROICexgc(5y)14.93%
ROCE(3y)8.99%
ROCE(5y)9.7%
ROICexcg growth 3Y-12.9%
ROICexcg growth 5Y14.21%
ROICexc growth 3Y-15.31%
ROICexc growth 5Y11.73%
OM growth 3Y-6.44%
OM growth 5Y11.16%
PM growth 3Y-11.25%
PM growth 5Y19.73%
GM growth 3Y-0.84%
GM growth 5Y-0.31%
F-Score6
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 7.35
Debt/EBITDA 1.22
Cap/Depr 67.11%
Cap/Sales 5.32%
Interest Coverage 3.98
Cash Conversion 74.59%
Profit Quality 175.97%
Current Ratio 1.16
Quick Ratio 1.13
Altman-Z 2.18
F-Score6
WACC5.65%
ROIC/WACC1.39
Cap/Depr(3y)71.13%
Cap/Depr(5y)62.13%
Cap/Sales(3y)5.6%
Cap/Sales(5y)5.1%
Profit Quality(3y)140.8%
Profit Quality(5y)194.45%
High Growth Momentum
Growth
EPS 1Y (TTM)41.21%
EPS 3Y5.8%
EPS 5Y35.88%
EPS Q2Q%-31.17%
EPS Next Y30.1%
EPS Next 2YN/A
EPS Next 3Y13.28%
EPS Next 5YN/A
Revenue 1Y (TTM)21.68%
Revenue growth 3Y19.22%
Revenue growth 5Y13.5%
Sales Q2Q%14.27%
Revenue Next Year8.5%
Revenue Next 2YN/A
Revenue Next 3Y18.3%
Revenue Next 5YN/A
EBIT growth 1Y58.61%
EBIT growth 3Y11.53%
EBIT growth 5Y26.17%
EBIT Next Year117.93%
EBIT Next 3Y42.23%
EBIT Next 5YN/A
FCF growth 1Y243.93%
FCF growth 3Y-16.35%
FCF growth 5Y34.22%
OCF growth 1Y66.41%
OCF growth 3Y-3.94%
OCF growth 5Y18.54%